Daniel J. Brennan, Vertex Pharmaceuticals Inc / MA grant

Director, SEC Form 4, filed on October 22, 2026
Daniel J. Brennan: all transactions
SEC filingVRTX insider historyVRTX stock page
+795 sharesnet change in holding. Not an open-market purchase or sale
Transaction date
October 20, 2026
Shares held after
795Direct ownership
Change in holding
Could not be calculatedFrom the transactions in the filing
Filing rows
1None is a purchase or sale

Price context

VRTX daily close, Apr 23 to October 23, 2026
$557.96$423.24
Daily close
Grants, options, tax
Transaction price
Not reportedNot an open-market trade
Close on trade date
$514.65October 20, 2026
Latest close
$523.93October 23, 2026
Since the trade
+1.80%vs the close on trade date

Transactions in the filing

DateTransactionSecuritySharesPriceAmountAfter
Grant
Common stockDirect
795
$503.47
$400,259
795

Recent filings at Vertex Pharmaceuticals Inc / MA

Full history
PersonTransactionAmount or sharesDate
Jasper van GrunsvenVice president
Grant
+8,682 shares
Kristen AmbroseChief accounting officer
Grant
+5,000 shares
Amit SachdevOfficer
Grant
+8,251 shares
Ourania TatsisOfficer
Grant
+8,251 shares